Search All News
New insights into the genetic architecture of schizophrenia hold promise for improved risk prediction and the development of better drugs to treat the disease.
A study by Columbia researchers found that between 1996 and 2016 the percentage of psychiatrist visits involving psychotherapy declined by half—dropping to only 21.6% of patient visits.
Five-year Columbia clinical trial indicates rapid cognitive shift diminishes suicidal thoughts, independently of improvement in depressive symptoms.
A new digital support tool, Columbia Psychiatry Pathways, strengthens the ability of clinicians to provide critical mental health services for individuals with major depression.
- September 29, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
- September 21, 2021
The National Academy of Medicine named Hankerson one of ten 2021 Emerging Leaders in Health and Medicine—scholars who are poised to shape the future of science, medicine, and health equity.
- August 11, 2021
With the help of brain imaging and a clip from the “The Good, the Bad, and the Ugly,” Columbia psychiatrists have discovered a part of the human brain necessary for understanding social interactions.
- December 22, 2020
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
- November 20, 2020
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation.
- November 13, 2020
A third of youths in New York City foster care identify as LGBTQAI+, finds a study by Columbia researcher Theo Sandfort. But why so many gender diverse youths end up in foster care is unclear.